AI assistant
Plus500 Ltd. — Director's Dealing 2020
Mar 9, 2020
6292_dirs_2020-03-09_65cbb10d-b0c4-42c4-9b3e-88cc35cb64a2.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 3591F
Plus500 Limited
09 March 2020
9 March 2020
Plus500 Ltd.
("Plus500" or "the Company")
PDMR Dealing
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
The following notification is made under article 19 of the Market Abuse Regulation.
1
Details of PDMR / person closely associated with them ("PCA")
(a)
Name
Omer Elazari
2
Reason for the notification
(a)
Position/status
PDMR
(b)
Initial notification/amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)
Name
Plus500 Ltd.
(b)
LEI
549300X8NGW9C5OJZU13
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a)
Description of the financial instrument
Identification code
Ordinary shares of NIS 0.01 par value ("Shares")
IL0011284465
(b)
Nature of the transaction
Purchase of Shares
(c)
Price(s) and volume(s)
| Prices (£) | Volumes |
| 9.350 | 10,000 |
| 9.355 | 220 |
| 9.360 | 9,780 |
| 9.400 | 10,000 |
| 9.446 | 1,100 |
| 9.450 | 8,900 |
| 9.460 | 10,044 |
| 9.466 | 300 |
| 9.468 | 365 |
| 9.470 | 9,291 |
| 9.498 | 300 |
| 9.500 | 9,700 |
(d)
Aggregated information
Price: £9.427
Volume: 70,000
(e)
Date of the transaction
6 March 2020
(f)
Place of the transaction
London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHFZGGFMRGGGZZ